Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 235-183-8 | CAS number: 12124-97-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1960
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: study was performed prior to the implementation of official testing guidelines
Data source
Reference
- Reference Type:
- publication
- Title:
- The Biological Half-life of Bromide ions in Human Blood
- Author:
- Söremark, R.
- Year:
- 1 960
- Bibliographic source:
- Acta physiol. Scand., 50, 119-123
Materials and methods
- Objective of study:
- other: biological half-life
Test guideline
- Qualifier:
- no guideline available
- Deviations:
- not applicable
- Remarks:
- study was performed prior to the implementation of official testing guidelines
- GLP compliance:
- no
Test material
- Reference substance name:
- Ammonium bromide
- EC Number:
- 235-183-8
- EC Name:
- Ammonium bromide
- Cas Number:
- 12124-97-9
- Molecular formula:
- BrH4N
- IUPAC Name:
- Bromide activated chloramine (BAC) generated from ammonium bromide and sodium hypochlorite
- Details on test material:
- - Name of test material (as cited in study report): Ammonium bromide
- Radiolabelling: 82Br in form of NH4Br
- No further details given on test material within the publication.
Constituent 1
- Radiolabelling:
- yes
- Remarks:
- 82Br in form of NH4Br
Test animals
- Species:
- human
- Strain:
- other: not applicable
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Not applicable
- Age at study initiation: between 19 and 23 years
- Weight at study initiation: women were within a weight range of 55-64 kg and men of 62-78 kg
Administration / exposure
- Route of administration:
- oral: drinking water
- Vehicle:
- water
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
10 µCi of 82Br in the form of NH4Br was dissolved in 25 ml water; this corresponds to less than 0.05 mg ammonium bromide (0.041 mg bromide). - Duration and frequency of treatment / exposure:
- single oral administration
Doses / concentrations
- Remarks:
- Doses / Concentrations:
10 µCi of 82Br in the form of NH4Br was dissolved in 25 ml water; this corresponds to less than 0.05 mg ammonium bromide (0.041 mg bromide)
- No. of animals per sex per dose / concentration:
- Four women and six men participated in the investigation
- Control animals:
- no
- Details on dosing and sampling:
- PHARMACOKINETIC STUDY (Absorption, distribution, excretion)
- Tissues and body fluids sampled : blood
- Time and frequency of sampling:Twice daily for a period of 4 days - Statistics:
- Not applicable
Results and discussion
Toxicokinetic / pharmacokinetic studies
- Details on absorption:
- No significant difference in the concentration, related to the time of the day at which the measurement was made, could be observed. The highest concentration was reached within 1-4 hours after the radioactive solution had been taken.
- Details on distribution in tissues:
- The individual concentration of radiobromide in blood cells was determined by measuring the 82Br concentration of the whole blood sample and of the sample of serum. The amount of 82Br ions transferred to the cells was calculated with the use of the haematocrit values. In the human subjects studied it was found that of the whole amount of 82Br in the blood, between 26 and 34% was transferred into the cells. The ratio red blood cells to serum of bromide ions was about 0.45.
In no case were significant amounts of 82Br observed in fat or proteins
- Details on excretion:
- The effective half-life of 82Br ions in human blood was found to be 32 hours and the biological half-life about 12 hours.
Toxicokinetic parametersopen allclose all
- Toxicokinetic parameters:
- other: effective half-life: 32 hours
- Toxicokinetic parameters:
- other: biological half-life: 12 hours
Any other information on results incl. tables
The concentration of82Br in the blood at different times after the oral administration of NH4Br solution revealed that the radioactivity varied between 200 and 400 counts/min/ml blood at five hours after82Br was given.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): no bioaccumulation potential based on study results , since in no case significant amounts of 82Br were observed in fat or proteins
From the investigation it can be concluded that the effective half-life of 82Br ions in human blood is 32 hours and the biological half-life about 12 hours. Bromide was preferentially distributed in the serum with a ratio red blood cells to serum of bromide ions of about 0.45. - Executive summary:
Materials and Methods
The biological half-life of bromide was studied in 10 human subjects. Radioactive isotope of bromide was given orally in form of ammonium bromide in water solution. Venous blood samples were drawn twice a day. In addition to the biological half-life, the bromide ratio red blood cells to serum was determined after measuring the individual haematocrit value in order to determine the amount of bromide transferred to blood cells.
Results and Discussion
Bromide belongs to those elements which are present in very small amounts in the body. An average value for human blood of 3.7 mg/L, had been found, however, with great individual variations. A ratio of Br/Cl of roughly 1:1000 was found in blood and urine. As the intake of bromide varies from one individual to another, a variation of the bromide level in blood might be expected. When the radioactivities in red cells and plasma were measured in this investigation, the haematocrit method was found to be accurate. For the same person the haematocrit varied less than 3%. The ratio blood cells to serum of bromide ions was found in previous investigations to be 0.75 and 0.55. In the present investigation the corresponding figure was found to be 0.45. As it was found that the bromide ions were not incorporated in fat or proteins of blood, it would seem that the amount of bromide ions inside the red cell membrane is probably distributed mainly in the intracellular water. Theconcentration of 82Br gradually decreased 2-3 hours after application via an exponential course characterized by the biological half-life, which illustrated the continuous exchange of bromide ions in the body caused by different mechanisms. The bromide ions are eliminated from the blood mainly by excretion into the urine. The amount of ammonium bromide administered to the subjects was considered to be sufficiently small not to disturb the physiological distribution.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.